Boston Scientific (BSX)
(Delayed Data from NYSE)
$74.50 USD
-0.66 (-0.88%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $74.72 +0.22 (0.30%) 7:16 PM ET
2-Buy of 5 2
C Value C Growth B Momentum C VGM
Price, Consensus and EPS Surprise
BSX 74.50 -0.66(-0.88%)
Will BSX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BSX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BSX
Merit Medical (MMSI) Q2 Earnings & Revenues Beat, '24 View Up
BD (BDX) Q3 Earnings Surpass Estimates, Margins Expand
BSX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Avanos (AVNS) Q2 Earnings Top Estimates, Gross Margin Contracts
QuidelOrtho (QDEL) Q2 Earnings Beat Estimates, U.S. Sales Down
Medtronic Stock Moves Above 50-Day SMA: Should You Buy MDT?
Other News for BSX
Catalyst Watch: Disney earnings, Costco sales update, MicroStrategy split, and eyes on AI patents
Blackstone Minerals Issues New Employee Incentive Options
Blackstone Advances pCAM Pilot and DFS Completion
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'
Terumo Gaining Share In Growth Markets, But Consistency Still A Question